Inhibition of apoptosis by ionomycin and zinc in peripheral blood mononuclear cells (PBMC) of leprosy patients

Clinical and Experimental Immunology

Volumn 117, Issue 1, 1999, Pages 56-62

  Gupta, A ^a,b   Sharma, V K ^a   Vohra, H ^a   Ganguly, N K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b Stern Building ^*  (United States)

Author keywords

Apoptosis; Ionomycin; Leprosy; Peripheral blood mononuclear cells; Zinc

Indexed keywords

INTERLEUKIN 2; IONOMYCIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; ZINC;

APOPTOSIS; ARTICLE; CALCIUM MOBILIZATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DRUG INHIBITION; HUMAN; HUMAN CELL; LEPROMATOUS LEPROSY; MONONUCLEAR CELL; PRIORITY JOURNAL; TUBERCULOID LEPROSY; WESTERN BLOTTING;

ANTIBODIES; APOPTOSIS; CALCIUM SIGNALING; CELLS, CULTURED; HUMANS; INTERLEUKIN-2; IONOMYCIN; LEPROSY; LEPROSY, LEPROMATOUS; LEPROSY, TUBERCULOID; LEUKOCYTES, MONONUCLEAR; MONENSIN; TUMOR NECROSIS FACTOR-ALPHA; ZINC;

EID: 0033049768     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00908.x     Document Type: Article

References (33)

1. Choudhuri K. The immunology of leprosy: Unraveling an enigma. Int J Lepr 1995; 63:430-47.
2. Ottenhoff THM. Immunology of leprosy: Lessons from and for leprosy. Int J Lepr 1994; 62:108-21.
3. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL. Defining protective responses to pathogens: Cytokine profiles in leprosy lesions. Science 1991; 254:277-9.
4. Haregewoin A, Godal T, Mustafa AS, Belehu A, Yamaneberhan T. T-cell conditioned media reverse T-cell unresponsiveness in lepromatous leprosy. Nature 1983; 303:342-4.
5. Garcia-Sanz JA, Lenig D. Translational control of Interleukin 2 messenger RNA as a molecular mechanism of T Cell anergy. J Exp Med 1996; 184:159-64.
6. Schwartz RH. Models of T-cell anergy: Is there a common molecular mechanism. J Exp Med 1996; 184:1-8.
7. Ridley DS, Jopling WH. Classification of leprosy according to immunity; a five group system. Int J Lepr 1996; 31:255-73.
8. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968; 77 (Suppl.):57-62.
9. Gouegean ML, Garcia S, Heeney J et al. Programmed cell death in AIDS-related HIV and SIV injections. AIDS Res Hum Retrovir 1993; 9:553-7.
10. Jung T, Schauer U, Heusser C, Neumann C, Reiger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993; 159:197-207.
11. Sander B, Andersson J, Andersson U. Assessment of cytokines by immunofluorescence and the paraformaldehyde saponin procedure. Immunol Res 1991; 119;65-93.
12. Harrer T, Wolf B, Nager W, Schwarz W, Bergner D, Kalden JR. In vitro activation of peripheral mononuclear cells by Zn in HIV infected patients and healthy controls. Clin Exp Immunol 1992; 89:285-9.
13. Osthoff KS. The fas/APO-1 receptor and its deadly ligand. Trends Cell Biol 1994; 4:421-6.
14. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 1995; 377:348-51.
15. Barnes PF, Chatterjee D, Brennan PJ, Rea TH. Tumor necrosis factor production in patients with leprosy. Infect Immun 1992; 60:1441-6.
16. Parida SK, Grau GE, Zaheer SA, Mukherjee R. Serum tumor necrosis factor and interleukin 1 in leprosy and during lepra reactions. Clin Immunol Immunopathol 1992; 62:23-27.
17. Sarno EN, Gruu GE, Vieira LMM, Nery JA. Serum levels of tumor necrosis factor-alpha and interleukin-1β during leprosy reactional states. Clin Exp Immunol 1991; 84:103-8.
18. Young SK, Rayment N, Brickell PM, Katz DR, Vinayakumar S, Colston MJ, Lockwood DNJ. Tumor necrosis factor-alpha (TNFα) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions. Clin Exp Immunol 1995; 99:196-202.
19. Sharma N. Mechanism of Activation of T Lymphocytes in Leprosy Spectrum. Thesis submitted to Postgraduate Institute of Medical Education and Research; Chandigarh, India: 1996.
20. Lancaster JS, Steinberg TH, Allen PM. Selective loss of calcium ion signalling pathway in T cells maturing towards a T-helper two phenotype. J Immunol 1997; 159:1160-8.
21. McConkey DJ, Orrenius S. Signal tranduction pathways to apoptosis. Trends Cell Biol 1994; 4:372-5.
22. Peitsch MC, Polzar B, Stephan H, Crompton T, Donald HR, MacMannherz HG, Tschopp J. Characterization of endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis. EMBO J 1993; 12:371-7.
23. George J, Bhatia VN, Balakrishnana S, Ramu G. Serum zinc/copper ratio on subtypes of leprosy and effect of zinc therapy on reactional states. Int J Lepr 1991; 59:20-24.
24. Jain A, Mukherjee A. Chattopadhya D, Saha K. Biometals in skin and sera of leprosy patients and their correlation to trace element contents of M. leprae and histological types of disease; a comparative study with cutaneous tuberculosis. Int J Lepr 1995; 63:249-58.
25. Seth NC, Madadi AJ, Bhandar S. Serum zinc, copper, magnesium protein and superoxide dismutase in leprosy on MDT. A follow up study. Ind J Lepr 1996; 68:325-33.
26. Vidal MC, Bottasso OA, Lehrer A, Puche RC. Altered calcium-binding ability of plasma proteins as a cause of hypocalcemia in lepromatous leprosy patients. Int J Lepr 1993; 61:586-91.
27. Mahajan PM, Jadhav VH, Patki AH, Jogaikar DG, Mehta JM. Oral Zn therapy in recurrent erythema nodosum leprosum: A clinical study. Ind J Lepr 1994; 66:51-57.
28. Mathur NK, Bumb RA, Mangal HN, Sharma ML. Oral zinc as an adjunct to dapsone in lepromatous leprosy. Int J Lepr 1984; 52:331-8.
29. S) gene expression. Eur J Immunol 1996; 26:294-9.
30. Driessen C, Hirv K, Kirchner H, Rink L. Divergent effects of different bacterial pathogenic agents. J Inf Dis 1995; 171:486-9.
31. Wellinghausen N, Kirchner H, Rink L. Immunobiology of zinc. Immunol Today 1997; 18:519-21.
32. Shannon EJ, Sandoval F. Thalidomide is agonistic to the synthesis of IL-2 and it can be agonistic or antagonistic to synthesis TNFα. Int J Lepr 1995; 63:654-6.
33. Lockwood DNJ. The management of erythema nodosum leprosum: Current and future options. Lepr Res 1996; 67:253-9.